Pre-ECMO team period (n = 70) | Post-ECMO team period (n = 46) | P value | |
---|---|---|---|
Initial ECMO configuration | 0.044 | ||
Femoro-jugular veno-venous | 60 (85.7) | 32 (69.6) | |
Femoro-femoral veno-venous | 8 (11.4) | 13 (28.3) | |
Femoro-femoral veno-arterial | 2 (2.9) | 0 (0.0) | |
Mixed (veno–veno-arterial) | 0 (0.0) | 1 (2.2) | |
Successful weaning off of ECMO | 30 (42.9) | 30 (65.2) | 0.018 |
Duration of ECMO support (days) | 10 (7–20) | 11 (4–27) | 0.674 |
Survivors | 9 (5–16) | 9 (4–23) | 0.755 |
Non-survivors | 15 (8–24) | 19 (3–27) | 0.754 |
Adverse events during ECMO | |||
ECMO-related complications | |||
Cannula | 23 (32.9) | 7 (15.2) | 0.034 |
Malposition requiring repositioning | 21 | 5 | |
Vessel perforation | 1 | 0 | |
Arterial cannulation | 1 | 0 | |
Accidental decannulation | 0 | 2 | |
Other | 11 (15.7) | 11 (23.9) | 0.271 |
Patient complications | |||
Hematological | 20 (28.6) | 10 (21.7) | 0.411 |
Neurological | 9 (12.9) | 1 (2.2) | 0.086 |
Cardiovasculara | 62 (88.6) | 30 (65.2) | 0.002 |
Inotrope or vasopressor use | 51 | 30 | |
Myocardial stunning | 3 | 0 | |
Arrhythmia | 19 | 5 | |
Cardiac tamponade | 1 | 0 | |
Cardiac arrest | 10 | 1 | |
Pulmonary | 23 (32.9) | 15 (32.6) | 0.978 |
Renal | 36 (51.4) | 23 (50.0) | 0.880 |
Infection | 36 (51.4) | 19 (41.3) | 0.285 |